glp-1 receptor agonists adverse effects of class drugs. Gastrointestinal issues are Comparison of adverse effects between
Description
They then performed 1:1 propensity score matching to create clinically comparable groups in three key analyses
65% of patients achieved more than 10% weight loss compared to 0% placebo
Tiwari AK, Kumar V, Yadav DP, et al
The dramatic amount of weight that study volunteers lost on the new drug exceeds the percentage of weight most people lose when they use the popular weight-loss drugs, Wegovy and Zepbound
& Bankir, L
When compared to other antihyperglycemic agents, patients with type 2 diabetes receiving GLP-1RAs therapy exhibit a lower risk of developing colorectal cancer [45]
